New HMS-CSSA Board Advisors

Sep - 01
2017

New HMS-CSSA Board Advisors

Dear All,

We are excited to announce that Dr. Yingzi Yang accepted our invitation to join our HMS-CSSA academic advisor committee, and Mr. Chesley Chen accepted our invitation to join our HMS-CSSA industrial advisor committee. As advisors, they will give advice to HMS-CSSA board members, host and give talks at seminars and annual symposium, and act a judge of our annual research award.  We believe that those world-renowned advisors will promote the prosperity of our HMS Chinese community in both scientific and industrial field.
Many thanks.

 
Cheers
HMS-CSSA Board
 
 

Yingzi Yang is a professor of Developmental Biology at   Harvard School of Dental Medicine. Dr. Yang received her B.S. degree from the Fudan University in China in 1988. She received her Ph.D. in Molecular Biology from the Weill Medical College of Cornell University in New York in 1996. After completing a postdoctoral fellowship with Professor Andrew McMahon at Harvard University, she joined the Genetic Disease Research Branch of the National Human Genome Research Institute (NHGRI) as a tenure–track investigator in 2000 and received tenure at NHGRI in 2006. She was recruited by HSDM as Professor of Developmental Biology in 2015. The Yang Lab uses molecular, cellular, genetic and genomic approaches to investigate critical roles of cell signaling in embryonic morphogenesis and adult physiology, mainly focusing on the mammalian limb, skeleton and liver, and exploiting these systems to explore human biology and address the underlying pathological mechanisms of diseases including cancer. Dr. Yang’s research and discovery have provided insight into several fundamental aspects of tissue and organ morphogenesis in the limb and skeleton and tumor formation in the liver.

Website: https://hsdm.harvard.edu/yang-laboratory

 

 
Chesley Chen SM, MBA, is Chief Executive Officer of Safety Partners, Inc., which provides environmental, health, and safety programs to over 200 life science and technology companies each year.  Chen is a serial entrepreneur and brings extensive experience in launching and scaling up early to mid-stage health technology, life science, and financial service ventures. He has over 30 years of experience in executive management, corporate strategy, client service, product development, operations, technology, and finance. He has worked for a wide range of firms including Health Dialog, Good Measures, Warner Babcock Institute for Green Chemistry, and Goldman Sachs.  Chen holds a BS in Civil Engineering from Tufts University, an SM in Aeronautics and Astronautics from MIT, and an MBA from the Harvard Business School.  As he continues on his career journey, he dedicates time to sharing his experiences about his path to CEO and his ongoing learnings. Outside of work, he devotes his time to family, rock climbing, martial arts, piano, and studying the arts and sciences. He is of Chinese heritage, the son and grandson of Chinese immigrants.